Advertisement

Implementing Home Blood Pressure Monitoring into Clinical Practice

  • Nadia Liyanage-Don
  • Deborah Fung
  • Erica Phillips
  • Ian M. KronishEmail author
Implementation to Increase Blood Pressure Control: What Works? (Jeffrey Brettler and Kristi Reynolds, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Implementation to Increase Blood Pressure Control: What Works?

Abstract

Purpose of Review

To review data supporting the use of home blood pressure monitoring (HBPM) and provide practical guidance to clinicians wishing to incorporate HBPM into their practice.

Recent Findings

HBPM more accurately reflects the risk of cardiovascular events than office blood pressure measurement. In addition, there is high-quality evidence that HBPM combined with clinical support improves blood pressure control. Therefore, HBPM is increasingly recommended by guidelines to confirm the diagnosis of hypertension and evaluate the efficacy of blood pressure-lowering medications. Nevertheless, HBPM use remains low due to barriers from the patient, clinician, and healthcare system level. Understanding these barriers is crucial for developing strategies to effectively implement HBPM into routine clinical practice.

Summary

HBPM is a valuable adjunct to office blood pressure measurement for diagnosing hypertension and guiding antihypertensive therapy. Following recommended best practices can facilitate the successful implementation of HBPM and impact how hypertension is managed in the primary care setting.

Keywords

Home blood pressure monitoring Ambulatory blood pressure monitoring Hypertension Screening Implementation Barriers 

Notes

Acknowledgments

Dr. Kronish and Dr. Phillips received support from the Agency for Healthcare Research and Quality (R01 HS024262.)

Compliance with Ethical Standards

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Smith N, et al. Screening for high blood pressure in adults: a systematic evidence review for the US Preventive Services Task Force. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Rockville (MD)2014.Google Scholar
  2. 2.
    Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.PubMedCrossRefGoogle Scholar
  3. 3.
    Bauer F, Seibert FS, Rohn B, Bauer KAR, Rolshoven E, Babel N, et al. Attended versus unattended blood pressure measurement in a real life setting. Hypertension. 2018;71(2):243–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Sharman JE, Howes FS, Head GA, McGrath BP, Stowasser M, Schlaich M, et al. Home blood pressure monitoring: Australian Expert Consensus Statement. J Hypertens. 2015;33(9):1721–8.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Band R, Bradbury K, Morton K, May C, Michie S, Mair FS, et al. Intervention planning for a digital intervention for self-management of hypertension: a theory-, evidence- and person-based approach. Implement Sci. 2017;12(1):25.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Siu AL. Force USPST. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(10):778–86.PubMedCrossRefGoogle Scholar
  7. 7.
    Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA. 2012;307(12):1273–83.PubMedCrossRefGoogle Scholar
  8. 8.
    Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Centers for Disease C, Prevention. CDC Grand Rounds: the million hearts initiative. MMWR Morb Mortal Wkly Rep. 2012;61(50):1017–21.Google Scholar
  10. 10.
    Michael Rakotz M. Improving blood pressure control: Measure, Act and Partner (M.A.P.) to help patients control blood pressure and ultimately prevent heart disease. 2015 [Available from: https://edhub.ama-assn.org/steps-forward/module/2702688. Accessed 20 Jan 2019
  11. 11.
    •• Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, et al. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138(17):e595–616 This systematic review and meta-analysis provides an estimate of the blood pressure and adverse cardiovascular event-lowering effect of self-measured blood pressure monitoring versus office blood pressure measurement.PubMedCrossRefGoogle Scholar
  12. 12.
    Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension. 2009;53(3):480–6.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303(20):2043–50.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Park S, Buranakitjaroen P, Chen CH, Chia YC, Divinagracia R, Hoshide S, et al. Expert panel consensus recommendations for home blood pressure monitoring in Asia: the Hope Asia Network. J Hum Hypertens. 2018;32(4):249–58.PubMedCrossRefGoogle Scholar
  15. 15.
    Cohen JB, Cohen DL. Integrating out-of-office blood pressure in the diagnosis and management of hypertension. Curr Cardiol Rep. 2016;18(11):112.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Birkett NJ. The effect of alternative criteria for hypertension on estimates of prevalence and control. J Hypertens. 1997;15(3):237–44.PubMedCrossRefGoogle Scholar
  17. 17.
    Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16(7):971–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Mori Y, et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension. 2014;64(5):989–96.PubMedCrossRefGoogle Scholar
  19. 19.
    Kario K, Saito I, Kushiro T, Teramukai S, Tomono Y, Okuda Y, et al. Morning home blood pressure is a strong predictor of coronary artery disease: the HONEST Study. J Am Coll Cardiol. 2016;67(13):1519–27.PubMedCrossRefGoogle Scholar
  20. 20.
    Hoshide S, Yano Y, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, et al. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population: the Japan Morning Surge-Home Blood Pressure Study. Hypertension. 2016;68(1):54–61.PubMedCrossRefGoogle Scholar
  21. 21.
    Niiranen TJ, Hanninen MR, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertension. 2010;55(6):1346–51.PubMedCrossRefGoogle Scholar
  22. 22.
    Tsunoda S, Kawano Y, Horio T, Okuda N, Takishita S. Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients. Hypertens Res. 2002;25(2):167–73.PubMedCrossRefGoogle Scholar
  23. 23.
    Mule G, Caimi G, Cottone S, Nardi E, Andronico G, Piazza G, et al. Value of home blood pressures as predictor of target organ damage in mild arterial hypertension. J Cardiovasc Risk. 2002;9(2):123–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Gaborieau V, Delarche N, Gosse P. Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage. J Hypertens. 2008;26(10):1919–27.PubMedCrossRefGoogle Scholar
  25. 25.
    Tachibana R, Tabara Y, Kondo I, Miki T, Kohara K. Home blood pressure is a better predictor of carotid atherosclerosis than office blood pressure in community-dwelling subjects. Hypertens Res. 2004;27(9):633–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Matsumoto A, Satoh M, Kikuya M, Ohkubo T, Hirano M, Inoue R, et al. Day-to-day variability in home blood pressure is associated with cognitive decline: the Ohasama Study. Hypertension. 2014;63(6):1333–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Imai Y, Ohkubo T, Sakuma M, Tsuji II, Satoh H, Nagai K, et al. Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: a prospective observation in a cohort from Ohasama, northern Japan. Blood Press Monit. 1996;1(3):251–4.PubMedGoogle Scholar
  28. 28.
    Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111(14):1777–83.PubMedCrossRefGoogle Scholar
  29. 29.
    Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies. J Hypertens. 2012;30(3):449–56.PubMedCrossRefGoogle Scholar
  30. 30.
    Fuchs SC, Mello RG, Fuchs FC. Home blood pressure monitoring is better predictor of cardiovascular disease and target organ damage than office blood pressure: a systematic review and meta-analysis. Curr Cardiol Rep. 2013;15(11):413.PubMedCrossRefGoogle Scholar
  31. 31.
    Noguchi Y, Asayama K, Staessen JA, Inaba M, Ohkubo T, Hosaka M, et al. Predictive power of home blood pressure and clinic blood pressure in hypertensive patients with impaired glucose metabolism and diabetes. J Hypertens. 2013;31(8):1593–602.PubMedCrossRefGoogle Scholar
  32. 32.
    Lv J, Ehteshami P, Sarnak MJ, Tighiouart H, Jun M, Ninomiya T, et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ. 2013;185(11):949–57.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Lv J, Neal B, Ehteshami P, Ninomiya T, Woodward M, Rodgers A, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis. PLoS Med. 2012;9(8):e1001293.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels—overview and meta-analyses of randomized trials. J Hypertens. 2014;32(12):2296–304.PubMedCrossRefGoogle Scholar
  35. 35.
    Stergiou GS, Kario K, Kollias A, McManus RJ, Ohkubo T, Parati G, et al. Home blood pressure monitoring in the 21st century. J Clin Hypertens (Greenwich). 2018;20(7):1116–21.CrossRefGoogle Scholar
  36. 36.
    Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D, et al. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52(1):1–9.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010;24(12):779–85.PubMedCrossRefGoogle Scholar
  38. 38.
    Krause T, Lovibond K, Caulfield M, McCormack T, Williams B, Guideline Development G. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37(4):253–390.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Cloutier L, Daskalopoulou SS, Padwal RS, Lamarre-Cliche M, Bolli P, McLean D, et al. A new algorithm for the diagnosis of hypertension in Canada. Can J Cardiol. 2015;31(5):620–30.PubMedCrossRefGoogle Scholar
  41. 41.
    •• Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269–324 This article summarizes the most up-to-date US hypertension practice guidelines. The guidelines include a recommended clinical protocol for conducting home blood pressure monitoring, as well as thresholds for diagnosing sustained hypertension, white coat hypertension, and masked hypertension.CrossRefGoogle Scholar
  42. 42.
    Fletcher BR, Hinton L, Bray EP, Hayen A, Hobbs FR, Mant J, et al. Self-monitoring blood pressure in patients with hypertension: an internet-based survey of UK GPs. Br J Gen Pract. 2016;66(652):e831–e7.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Stergiou GS, Baibas NM, Gantzarou AP, Skeva II, Kalkana CB, Roussias LG, et al. Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy. Am J Hypertens. 2002;15(2 Pt 1):101–4.PubMedCrossRefGoogle Scholar
  44. 44.
    Warren RE, Marshall T, Padfield PL, Chrubasik S. Variability of office, 24-hour ambulatory, and self-monitored blood pressure measurements. Br J Gen Pract. 2010;60(578):675–80.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Ragot S, Genes N, Vaur L, Herpin D. Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response. Am J Hypertens. 2000;13(6 Pt 1):632–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, de la Figuera-Von Wichmann M, Casado-Martinez JJ, Martin-de Pablos JL, et al. Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. J Hypertens. 2006;24(1):169–75.PubMedCrossRefGoogle Scholar
  47. 47.
    Fletcher BR, Hinton L, Hartmann-Boyce J, Roberts NW, Bobrovitz N, McManus RJ. Self-monitoring blood pressure in hypertension, patient and provider perspectives: a systematic review and thematic synthesis. Patient Educ Couns. 2016;99(2):210–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Jones MI, Greenfield SM, Bray EP, Baral-Grant S, Hobbs FD, Holder R, et al. Patients’ experiences of self-monitoring blood pressure and self-titration of medication: the TASMINH2 trial qualitative study. Br J Gen Pract. 2012;62(595):e135–42.PubMedCrossRefGoogle Scholar
  49. 49.
    Stergiou GS, Bliziotis IA. Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review. Am J Hypertens. 2011;24(2):123–34.PubMedCrossRefGoogle Scholar
  50. 50.
    Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011;57(1):29–38.PubMedCrossRefGoogle Scholar
  51. 51.
    Ishikawa J, Hoshide S, Eguchi K, Ishikawa S, Shimada K, Kario K, et al. Nighttime home blood pressure and the risk of hypertensive target organ damage. Hypertension. 2012;60(4):921–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Ishikawa J, Shimizu M, Sugiyama Edison E, Yano Y, Hoshide S, Eguchi K, et al. Assessment of the reductions in night-time blood pressure and dipping induced by antihypertensive medication using a home blood pressure monitor. J Hypertens. 2014;32(1):82–9.PubMedGoogle Scholar
  53. 53.
    Ushio H, Ishigami T, Araki N, Minegishi S, Tamura K, Okano Y, et al. Utility and feasibility of a new programmable home blood pressure monitoring device for the assessment of nighttime blood pressure. Clin Exp Nephrol. 2009;13(5):480–5.PubMedCrossRefGoogle Scholar
  54. 54.
    Stergiou GS, Triantafyllidou E, Cholidou K, Kollias A, Destounis A, Nasothimiou EG, et al. Asleep home blood pressure monitoring in obstructive sleep apnea: a pilot study. Blood Press Monit. 2013;18(1):21–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Task Force CPS. Self-measured blood pressure monitoring improves outcomes: recommendation of the Community Preventive Services Task Force. Am J Prev Med. 2017;53(3):e115–e8.PubMedCrossRefGoogle Scholar
  56. 56.
    Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med. 2013;159(3):185–94.PubMedCrossRefGoogle Scholar
  57. 57.
    •• Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med. 2017;14(9):e1002389 This study conducts a systematic review and meta-analysis of the effect of blood pressure self-monitoring with and without clinician support on blood pressure control.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010;376(9736):163–72.PubMedCrossRefGoogle Scholar
  59. 59.
    Kaambwa B, Bryan S, Jowett S, Mant J, Bray EP, Hobbs FD, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis. Eur J Prev Cardiol. 2014;21(12):1517–30.PubMedCrossRefGoogle Scholar
  60. 60.
    McManus RJ, Mant J, Haque MS, Bray EP, Bryan S, Greenfield SM, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 2014;312(8):799–808.PubMedCrossRefGoogle Scholar
  61. 61.
    • McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391(10124):949–59 This article describes the results of a pragmatic randomized clinical trial that compares self-monitored blood pressure with and without telemonitoring versus office blood pressure management of hypertension. The authors found that self-monitored blood pressure with or without telemonitoring was superior to office blood pressure management, resulting in a 4.7-mmHg and 3.5-mmHg reduction in blood pressure, respectively.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Salazar MR, Espeche WG, Stavile RN, Balbin E, Leiva Sisnieguez BC, Leiva Sisnieguez CE, et al. Could self-measured office blood pressure be a hypertension screening tool for limited-resources settings? J Hum Hypertens. 2018;32(6):415–22.PubMedCrossRefGoogle Scholar
  63. 63.
    Stergiou GS, Salgami EV, Tzamouranis DG, Roussias LG. Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon? Am J Hypertens. 2005;18(6):772–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Furusawa EA, Filho UD, Junior DM, Koch VH. Home and ambulatory blood pressure to identify white coat and masked hypertension in the pediatric patient. Am J Hypertens. 2011;24(8):893–7.PubMedCrossRefGoogle Scholar
  65. 65.
    Nasothimiou EG, Tzamouranis D, Rarra V, Roussias LG, Stergiou GS. Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension. Hypertens Res. 2012;35(7):750–5.PubMedCrossRefGoogle Scholar
  66. 66.
    Zhang L, Li Y, Wei FF, Thijs L, Kang YY, Wang S, et al. Strategies for classifying patients based on office, home, and ambulatory blood pressure measurement. Hypertension. 2015;65(6):1258–65.PubMedCrossRefGoogle Scholar
  67. 67.
    Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47(5):846–53.PubMedCrossRefGoogle Scholar
  68. 68.
    Satoh M, Asayama K, Kikuya M, Inoue R, Metoki H, Hosaka M, et al. Long-term stroke risk due to partial white-coat or masked hypertension based on home and ambulatory blood pressure measurements: the Ohasama Study. Hypertension. 2016;67(1):48–55.PubMedCrossRefGoogle Scholar
  69. 69.
    Anstey DE, Muntner P, Bello NA, Pugliese DN, Yano Y, Kronish IM, et al. Diagnosing masked hypertension using ambulatory blood pressure monitoring, home blood pressure monitoring, or both? Hypertension. 2018;72(5):1200–7.PubMedCrossRefGoogle Scholar
  70. 70.
    Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Role of ambulatory and home blood pressure monitoring in clinical practice: a narrative review. Ann Intern Med. 2015;163(9):691–700.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Stergiou GS, Alpert B, Mieke S, Asmar R, Atkins N, Eckert S, et al. A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) collaboration statement. Hypertension. 2018;71(3):368–74.PubMedCrossRefGoogle Scholar
  72. 72.
    • Bello NA, Woolley JJ, Cleary KL, Falzon L, Alpert BS, Oparil S, et al. Accuracy of blood pressure measurement devices in pregnancy: a systematic review of validation studies. Hypertension. 2018;71(2):326–35 This article informs home blood pressure monitoring protocols by providing empiric data on how increasing the frequency of home blood pressure readings affects the reliability of home blood pressure estimates. Among patients without severely elevated blood pressure, as few as 3 days of HBPM readings may be sufficient to obtain reliable blood pressure estimates.PubMedCrossRefGoogle Scholar
  73. 73.
    Eguchi K, Kuruvilla S, Ishikawa J, Schwartz JE, Pickering TG. A novel and simple protocol for the validation of home blood pressure monitors in clinical practice. Blood Press Monit. 2012;17(5):210–3.PubMedCrossRefGoogle Scholar
  74. 74.
    O’Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001;322(7285):531–6.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Handler J. The importance of accurate blood pressure measurement. Perm J. 2009;13(3):51–4.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Parati G, Dolan E, McManus RJ, Omboni S. Home blood pressure telemonitoring in the 21st century. J Clin Hypertens (Greenwich). 2018;20(7):1128–32.CrossRefGoogle Scholar
  77. 77.
    Bello NA, Schwartz JE, Kronish IM, Oparil S, Anstey DE, Wei Y, et al. Number of measurements needed to obtain a reliable estimate of home blood pressure: results from the improving the detection of hypertension study. J Am Heart Assoc. 2018;7(20):e008658.PubMedCrossRefGoogle Scholar
  78. 78.
    Wood PW, Boulanger P, Padwal RS. Home blood pressure telemonitoring: rationale for use, required elements, and barriers to implementation in Canada. Can J Cardiol. 2017;33(5):619–25.PubMedCrossRefGoogle Scholar
  79. 79.
    Omboni S, Caserini M, Coronetti C. Telemedicine and M-health in hypertension management: technologies, applications and clinical evidence. High Blood Press Cardiovasc Prev. 2016;23(3):187–96.PubMedCrossRefGoogle Scholar
  80. 80.
    Jones MI, Greenfield SM, Bray EP, Hobbs FR, Holder R, Little P, et al. Patient self-monitoring of blood pressure and self-titration of medication in primary care: the TASMINH2 trial qualitative study of health professionals’ experiences. Br J Gen Pract. 2013;63(611):e378–85.PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Morrissey EC, Glynn LG, Casey M, Walsh JC, Molloy GJ. New self-management technologies for the treatment of hypertension: general practitioners’ perspectives. Fam Pract. 2018;35(3):318–22.PubMedCrossRefGoogle Scholar
  82. 82.
    Park JS, Rhee MY, Namgung J, Lee SY, Cho DK, Choi TY, et al. Comparison of optimal diagnostic thresholds of hypertension with home blood pressure monitoring and 24-hour ambulatory blood pressure monitoring. Am J Hypertens. 2017;30(12):1170–6.PubMedCrossRefGoogle Scholar
  83. 83.
    Muntner P, Carey RM, Jamerson K, Wright JT Jr, Whelton PK. Rationale for ambulatory and home blood pressure monitoring thresholds in the 2017 American College of Cardiology/American Heart Association Guideline. Hypertension. 2019;73(1):33–8.PubMedCrossRefGoogle Scholar
  84. 84.
    Hanninen MR, Niiranen TJ, Puukka PJ, Johansson J, Jula AM. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home study. J Hypertens. 2012;30(4):705–12.PubMedCrossRefGoogle Scholar
  85. 85.
    Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, et al. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension. 2014;63(4):675–82.PubMedCrossRefGoogle Scholar
  86. 86.
    Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, et al. Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension: analysis from the Dallas Heart Study. J Am Coll Cardiol. 2015;66(20):2159–69.PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Franklin SS, Thijs L, Hansen TW, O’Brien E, Staessen JA. White-coat hypertension: new insights from recent studies. Hypertension. 2013;62(6):982–7.PubMedCrossRefGoogle Scholar
  88. 88.
    Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018;378(16):1509–20.PubMedCrossRefGoogle Scholar
  89. 89.
    Diaz KM, Veerabhadrappa P, Brown MD, Whited MC, Dubbert PM, Hickson DA. Prevalence, determinants, and clinical significance of masked hypertension in a population-based sample of African Americans: the Jackson Heart Study. Am J Hypertens. 2015;28(7):900–8.PubMedCrossRefGoogle Scholar
  90. 90.
    Drawz PE, Alper AB, Anderson AH, Brecklin CS, Charleston J, Chen J, et al. Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage. Clin J Am Soc Nephrol. 2016;11(4):642–52.PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Ostchega YZG, Kit BK, Nwankwo T. Factors associated with home blood pressure monitoring among US adults: National Health and Nutrition Examination Survey, 2011-2014. Am J Hypertens. 2017;30(11):1126–32.PubMedCrossRefGoogle Scholar
  92. 92.
    Dymek JSA, Polak W, Gołda A. Assessment of knowledge and skills of patients with hypertension related to self-measurement of blood pressure (SBPM). Arterial Hypertension. 2015;1(1):39–44.CrossRefGoogle Scholar
  93. 93.
    Mondal S, Mondal H, Dutta R, Pal A, Acharya SS, Baidya C. Competency in home blood pressure monitoring and effect of training program on competency 2018.Google Scholar
  94. 94.
    Akpolat TAM, Sengul S, Derici U, Ulusoy S, Erturk S, Erdem Y. Home sphygmomanometers can help in the control of blood pressure: a nationwide field survey. Hypertens Res. 2018;41(6):460–8.PubMedCrossRefGoogle Scholar
  95. 95.
    Milot JP, Birnbaum L, Larochelle P, Wistaff R, Laskine M, Van Nguyen P, et al. Unreliability of home blood pressure measurement and the effect of a patient-oriented intervention. Can J Cardiol. 2015;31(5):658–63.PubMedCrossRefGoogle Scholar
  96. 96.
    Logan AG, Dunai A, McIsaac WJ, Irvine MJ, Tisler A. Attitudes of primary care physicians and their patients about home blood pressure monitoring in Ontario. J Hypertens. 2008;26(3):446–52.PubMedCrossRefGoogle Scholar
  97. 97.
    Doane J, Buu J, Penrod MJ, Bischoff M, Conroy MB, Stults B. Measuring and managing blood pressure in a primary care setting: a pragmatic implementation study. J Am Board Fam Med. 2018;31(3):375–88.PubMedCrossRefGoogle Scholar
  98. 98.
    Carrera PM, Lambooij MS. Implementation of out-of-office blood pressure monitoring in the Netherlands: from clinical guidelines to patients’ adoption of innovation. Medicine (Baltimore). 2015;94(43):e1813.CrossRefGoogle Scholar
  99. 99.
    • Carter EJ, Moise N, Alcantara C, Sullivan AM, Kronish IM. Patient barriers and facilitators to ambulatory and home blood pressure monitoring: a qualitative study. Am J Hypertens. 2018;31(8):919–27 This study highlights barriers and facilitators to home blood pressure monitoring from the perspective of patients recruited from underserved areas of New York City.PubMedCrossRefGoogle Scholar
  100. 100.
    Wood S, Greenfield SM, Sayeed Haque M, Martin U, Gill PS, Mant J, et al. Influence of ethnicity on acceptability of method of blood pressure monitoring: a cross-sectional study in primary care. Br J Gen Pract. 2016;66(649):e577–86.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Tirabassi J, Fang J, Ayala C. Attitudes of primary care providers and recommendations of home blood pressure monitoring—DocStyles, 2010. J Clin Hypertens (Greenwich). 2013;15(4):224–9.CrossRefGoogle Scholar
  102. 102.
    Chalmers J, Arima H, Harrap S, Touyz RM, Park JB. Global survey of current practice in management of hypertension as reported by societies affiliated with the International Society of Hypertension. J Hypertens. 2013;31(5):1043–8.PubMedCrossRefGoogle Scholar
  103. 103.
    Martín-Rioboó E, Pérula de Torres LA, Banegas JR, Lobos-Bejarano JM, Brotons Cuixart C, García Criado EI, et al. Knowledge, availability, and use of ambulatory and home blood pressure monitoring in primary care in Spain: the MAMPA study. J Hypertens. 2018;36(5):1051–8.PubMedCrossRefGoogle Scholar
  104. 104.
    • Kronish IM, Kent S, Moise N, Shimbo D, Safford MM, Kynerd RE, et al. Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States. J Am Soc Hypertens. 2017;11(9):573–80 This study describes key barriers to home blood pressure monitoring from the perspective of primary care physicians practicing in two regions of the USA.PubMedPubMedCentralCrossRefGoogle Scholar
  105. 105.
    Robins LS, Jackson JE, Green BB, Korngiebel D, Force RW, Baldwin LM. Barriers and facilitators to evidence-based blood pressure control in community practice. J Am Board Fam Med. 2013;26(5):539–57.PubMedCrossRefGoogle Scholar
  106. 106.
    Bradbury K, Morton K, Band R, May C, McManus R, Little P, et al. Understanding how primary care practitioners perceive an online intervention for the management of hypertension. BMC Med Inform Decis Mak. 2017;17(1):5.PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Arrieta A, Woods JR, Qiao N, Jay SJ. Cost-benefit analysis of home blood pressure monitoring in hypertension diagnosis and treatment: an insurer perspective. Hypertension. 2014;64(4):891–6.PubMedCrossRefGoogle Scholar
  108. 108.
    Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FD, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011;378(9798):1219–30.PubMedCrossRefGoogle Scholar
  109. 109.
    Soghikian K, Casper SM, Fireman BH, Hunkeler EM, Hurley LB, Tekawa IS, et al. Home blood pressure monitoring. Effect on use of medical services and medical care costs. Med Care. 1992;30(9):855–65.PubMedCrossRefGoogle Scholar
  110. 110.
    Reed SD, Li Y, Oddone EZ, Neary AM, Orr MM, Grubber JM, et al. Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension. Am J Hypertens. 2010;23(2):142–8.PubMedCrossRefGoogle Scholar
  111. 111.
    Cacciolati C, Tzourio C, Dufouil C, Alperovitch A, Hanon O. Feasibility of home blood pressure measurement in elderly individuals: cross-sectional analysis of a population-based sample. Am J Hypertens. 2012;25(12):1279–85.PubMedGoogle Scholar
  112. 112.
    Mills KT, Obst KM, Shen W, Molina S, Zhang HJ, He H, et al. Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and meta-analysis. Ann Intern Med. 2018;168(2):110–20.PubMedCrossRefGoogle Scholar
  113. 113.
    Kumar N, Khunger M, Gupta A, Garg N. A content analysis of smartphone-based applications for hypertension management. J Am Soc Hypertens. 2015;9(2):130–6.PubMedCrossRefGoogle Scholar
  114. 114.
    Hwang KO, Thomas EJ, Petersen LA. Use of home blood pressure results for assessing the quality of care for hypertension. JAMA. 2018;320(17):1753–4.PubMedCrossRefGoogle Scholar
  115. 115.
    Liao JM, Navathe AS, Press MJ. Medicare’s approach to paying for services that promote coordinated care. JAMA. 2018.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Nadia Liyanage-Don
    • 1
  • Deborah Fung
    • 2
  • Erica Phillips
    • 2
  • Ian M. Kronish
    • 1
    Email author
  1. 1.Center for Behavioral Cardiovascular HealthColumbia University Medical CenterNew YorkUSA
  2. 2.Division of General Internal MedicineWeill Cornell MedicineNew YorkUSA

Personalised recommendations